Stoke Therapeutics (NASDAQ:STOK – Get Free Report) released its earnings results on Monday. Stoke Therapeutics had a negative net margin of 529.20% and a negative return on equity of 48.84%. Stoke Therapeutics Stock PerformanceSTOK stock opened at $29.56 on Tuesday. Stoke Therapeutics has a 52 week low of $12.71 and a 52 week high of $40.22. See AlsoReceive News & Ratings for Stoke Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stoke Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.